SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-183292
Filing Date
2024-07-24
Accepted
2024-07-24 06:50:56
Documents
18
Period of Report
2024-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d597787d8k.htm   iXBRL 8-K 41716
2 EX-10.1 d597787dex101.htm EX-10.1 70288
3 EX-10.2 d597787dex102.htm EX-10.2 6129
4 EX-99.1 d597787dex991.htm EX-99.1 11511
9 GRAPHIC g597787g0724085501980.jpg GRAPHIC 3654
  Complete submission text file 0001193125-24-183292.txt   331272

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA engn-20240722.xsd EX-101.SCH 3521
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE engn-20240722_def.xml EX-101.DEF 14197
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE engn-20240722_lab.xml EX-101.LAB 23226
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE engn-20240722_pre.xml EX-101.PRE 15045
20 EXTRACTED XBRL INSTANCE DOCUMENT d597787d8k_htm.xml XML 5902
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 241136075
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)